Hospital-acquired Infection Diagnostics Market was valued at USD 3.5 Billion in 2022 and is projected to reach USD 5.6 Billion by 2030, growing at a CAGR of 7.5% from 2024 to 2030.
The global hospital-acquired infection (HAI) diagnostics market was valued at approximately USD 5.7 billion in 2022 and is projected to reach around USD 8.9 billion by 2028. This represents a robust compound annual growth rate (CAGR) of 7.8% during the forecast period. The market growth is driven by the increasing prevalence of HAIs, advancements in diagnostic technologies, and rising awareness about infection control. The rising adoption of rapid diagnostic tests and molecular diagnostics are key factors contributing to the expansion of the market. Additionally, increasing investments in healthcare infrastructure and the growing emphasis on improving hospital hygiene practices further support the market's upward trajectory.
Opportunities in the HAI diagnostics market are expanding with the surge in healthcare expenditure and the growing focus on personalized medicine. Emerging markets, particularly in Asia-Pacific and Latin America, are experiencing accelerated growth due to improving healthcare facilities, increasing patient population, and supportive government initiatives. The integration of artificial intelligence and machine learning in diagnostic tools is also set to offer significant growth prospects. The market's opportunity landscape includes innovations in diagnostic technologies, increased focus on infection prevention, and strategic collaborations to enhance diagnostic capabilities in emerging regions.
Get an In-Depth Research Analysis of the Global Hospital-acquired Infection Diagnostics Market Size And Forecast [2025-2032]
Abbott Laboratories
Advan DX
Abbott
Astrazeneca PLC
Bayer Schering Pharma LLC
Becton Dickinson And Company
Cepheid Inc.
Roche AG
Daiichi Sankyo
Hologic
Inc.
By the year 2030, the scale for growth in the market research industry is reported to be above 120 billion which further indicates its projected compound annual growth rate (CAGR), of more than 5.8% from 2023 to 2030. There have also been disruptions in the industry due to advancements in machine learning, artificial intelligence and data analytics There is predictive analysis and real time information about consumers which such technologies provide to the companies enabling them to make better and precise decisions. The Asia-Pacific region is expected to be a key driver of growth, accounting for more than 35% of total revenue growth. In addition, new innovative techniques such as mobile surveys, social listening, and online panels, which emphasize speed, precision, and customization, are also transforming this particular sector.
Get Discount On The Purchase of the Global Hospital-acquired Infection Diagnostics Market Size And Forecast [2025-2032]
Growing demand for below applications around the world has had a direct impact on the growth of the Global Hospital-acquired Infection Diagnostics Market
Hospital
Clinics
Ambulatory Surgery Centers (ASC)
Others
Based on Types the Market is categorized into Below types that held the largest Hospital-acquired Infection Diagnostics market share In 2023.
Instrument and Reagents
Consumables
Global (United States, Global and Mexico)
Europe (Germany, UK, France, Italy, Russia, Turkey, etc.)
Asia-Pacific (China, Japan, Korea, India, Australia, Indonesia, Thailand, Philippines, Malaysia and Vietnam)
South America (Brazil, Argentina, Columbia, etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
For More Information or Query, Visit @ Hospital-acquired Infection Diagnostics Market Research Analysis
1. Introduction of the Global Hospital-acquired Infection Diagnostics Market
Overview of the Market
Scope of Report
Assumptions
2. Executive Summary
3. Research Methodology of Verified Market Reports
Data Mining
Validation
Primary Interviews
List of Data Sources
4. Global Hospital-acquired Infection Diagnostics Market Outlook
Overview
Market Dynamics
Drivers
Restraints
Opportunities
Porters Five Force Model
Value Chain Analysis
5. Global Hospital-acquired Infection Diagnostics Market, By Type
6. Global Hospital-acquired Infection Diagnostics Market, By Application
7. Global Hospital-acquired Infection Diagnostics Market, By Geography
Global
Europe
Asia Pacific
Rest of the World
8. Global Hospital-acquired Infection Diagnostics Market Competitive Landscape
Overview
Company Market Ranking
Key Development Strategies
9. Company Profiles
10. Appendix
About Us: Verified Market Reports
Verified Market Reports is a leading Global Research and Consulting firm servicing over 5000+ global clients. We provide advanced analytical research solutions while offering information-enriched research studies. We also offer insights into strategic and growth analyses and data necessary to achieve corporate goals and critical revenue decisions.
Our 250 Analysts and SMEs offer a high level of expertise in data collection and governance using industrial techniques to collect and analyze data on more than 25,000 high-impact and niche markets. Our analysts are trained to combine modern data collection techniques, superior research methodology, expertise, and years of collective experience to produce informative and accurate research.
Contact us:
Mr. Edwyne Fernandes
US: +1 (650)-781-4080
US Toll-Free: +1 (800)-782-1768
Website: https://www.verifiedmarketreports.com/